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Abstract 
Intensity modulated radiation therapy (IMRT) is one of a standard treatment for localized prostate cancer. Although 
lower complication is expected for smaller target margin, determination of optimal margin is important. For bony-
structure based registration, internal prostate motion is the main factor determining the margin from clinical target 
volume to planning target volume. The purpose of this study was to measure interfractional internal motion of the 
prostate and to identity the factors which enlarge or reduce the margin, with special focus on patients’ anatomical 
characteristics. The 586 image sets of 16 patients acquired with megavoltage cone beam computed tomography 
were analyzed. For each patient, prostate shift in three directions was recorded for each fraction to calculate the 
required margin. Correlations between these values and patients’ anatomical characteristics were evaluated. The 
posteriorly required margin correlated positively with rectal volume and rectal mean area (p = 0.015 and p = 0.008), 
while random error in lateral, craniocaudal and anteroposterior direction correlated negatively (p = 0.014, 0.04 and 
0.0026, respectively) with body mass index (BMI). In addition to the previously identified factor of distended rectum, 
BMI was newly identified as another significant factor influencing interfractional internal prostate motion.
Keywords: Prostate cancer, Internal motion, Interfractional motion, Megavoltage cone beam computed 
tomography, Body mass index
© 2015 Maruoka et al. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License 
(http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, 
provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, 
and indicate if changes were made.
Background
External beam radiotherapy (EBRT) is a main therapeu-
tic modality for localized prostate cancer (Mohler et  al. 
2012). Some randomized studies have demonstrated 
the efficacy of dose-escalated EBRT for the treatment 
of localized prostate cancer (Dearnaley et  al. 2007; Al-
Mamgani et al. 2008; Kuban et al. 2011), but such efficacy 
often involves a trade-off in the form of heightened rectal 
toxicity. Intensity modulated radiation therapy (IMRT) is 
an improved version of EBRT that produces a steep dose 
gradient between the prostate and the surrounding risk 
organs such as rectum and bladder. EBRT using IMRT 
can deliver a higher dose to the prostate while keep-
ing the dose to risk organs low, but the steep dose gra-
dient results in a higher risk of setup error and internal 
prostate motion than with previous procedures. In fact, 
the National Comprehensive Cancer Network (NCCN) 
guidelines require image guided radiation therapy (IGRT) 
if the prescription dose is 78 Gy or more.
The common procedures for image guidance include 
trans-abdominal ultrasonography (US), in-room helical 
computed tomography (CT), on-board cone beam CT 
(megavoltage or kilovoltage), and electric portal imaging 
devices (EPID) with or without implanted fiducial mark-
ers (Stephans et  al. 2010; Soete et  al. 2008). Although 
these modalities are helpful for accurate patient set up, 
each procedure has some disadvantages. The accuracy of 
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trans-abdominal US is affected by the technical capabil-
ity of the performer, and organ displacement may occur 
due to image acquisition (Soete et al. 2008). Image guid-
ance by in-room or cone beam CT requires extra medical 
staff and generates increased radiation exposure for the 
patients, especially for prostate based registration. EPID 
is an older technique but it is still widely used for bony 
structures-based registration. Although target position 
can be identified with fiducial markers, implantation of 
fiducial markers is invasive. Although the prostate-based 
registration may preferable for IMRT, bony structures-
based registration is still majority of the image-guided 
radiotherapy because of its simplicity, convenience, and 
less invasiveness. For bone-matching registration, inter-
nal prostate motion is the main factor which defines the 
margin from clinical target volume (CTV) to planning 
target volume (PTV). The purpose of this study was to 
measure interfractional internal motion of the pros-
tate and to identify the factors which enlarge or reduce 




This study was performed with permission of the Insti-
tutional Review Board of our hospital. Between October 
2010 and May 2011, 16 patients with localized prostate 
cancer participated in this clinical trial. All of them were 
informed of this clinical trial and agreed by document to 
the participation in this study. All of them completed the 
study regimen. The patient distribution for T-stage was 
T1: T2: T3 = 5: 7: 4, for the Gleason score ≤6: 7: 8≤ = 6: 
4: 6, for the pretreatment prostate-specific antigen level 
<10 ng/ml: 10–20 ng/ml: 20 ng/ml< = 7: 5: 4, and for low: 
intermediate: high risk = 3: 6: 7. The definitions of these 
factors were derived from the NCCN guidelines. Table 1 
shows the patients’ anatomical characteristics which we 
considered to be candidates for affecting interfractional 
internal motion of the prostate.
Radiotherapy, acquisition of registry image, 
and measurement of prostate shift
Oncor Impression PLUS™ with a megavoltage cone beam 
CT (MV-CBCT) system (MVisionTM; Siemens Medical 
Solutions, Concord, CA, USA) was used. Patients emp-
tied their rectum in the morning of CT simulation as well 
as their bladder 30  min before CT simulation. Patients 
were immobilized in supine position using Vac-Lok™ 
Cushions (CIVCO Medical Solutions, Orange City, IA, 
USA). Contouring was performed by an experienced 
radiation oncologist. CTV was defined as the prostate 
plus the medial part of seminal vesicles, and PTV as 
CTV plus 5  mm margin in all directions. The prescrip-
tion dose was 70 Gy/35 fractions for low risk group and 
74  Gy/37 fractions for intermediate or high risk group, 
respectively. The dose was normalized to cover 95  % of 
PTV with prescribed dose. Dose-volume constraints for 
risk organs were: rectum V45Gy <35  %, V65Gy <17  %, 
bladder V40Gy <50 %, V65Gy <25 %, femoral head Dmax 
<50 Gy, and small intestine Dmax <60 Gy. All the patients 
were treated with step-and-shoot IMRT.
We used a unique technique, described elsewhere 
(Akino et al. 2012), for image guidance that involved MV-
CBCT and its characteristic treatment planning method. 
The dose for image guidance had been assigned as 15 
monitor units (MU), which was considered part of the 
treatment dose. The normal step-and-shoot IMRT beam 
arrangements were then made by using the reoptimization 
process. As a typical example, 2 Gy per fraction comprised 
the daily MV-CBCT dose of 0.1 Gy (corresponding to 15 
MU) and the usual IMRT beam dose of 1.9 Gy. Increased 
MU MV-CBCT can be used to identify soft-tissue struc-
ture such as the prostate (Morin et  al. 2006), although 
its image quality is second to that of CT using kV energy 
(Morrow et  al. 2012). Before the daily administration of 
step-and-shoot IMRT, 15 MU-MV-CBCT was acquired 
and the patient’s position was three-dimensionally cor-
rected based on bone structure by radiotherapists with or 
without aid of the auto-correcting function. If rectal gas 
was apparent on MV-CBCT, a soft catheter was used for 
gas suction. No correction based on prostate matching 
was performed before the actual IMRT beam delivery. All 
the MV-CBCT images were then reviewed retrospectively 
by radiation oncologists in order to evaluate shift of the 
prostate from the original position determined at the CT 
simulation stage and measured in three directions (lateral, 
craniocaudal and anteroposterior). The extent of shift was 
measured when the radiation oncologists had determined 
the optimal position. This was done by overlaying the pros-
tate on MV-CBCT images onto the contour of the prostate 
delineated at the treatment planning using CT simulation 
images. Deformation or rotational shift of the prostate was 
not taken into consideration.
Table 1 Patients’ anatomical characteristics
a Rectal volume was measured from the 2-cm above the prostate base level to 
the 2-cm below the prostate apex level
b Rectal mean area was calculated as rectal volume divided by its length in 
craniocaudal direction
Variables Means (range)
Age (years old) 71.5 (60–81)
BMI (kg/m2) 23.8 (14.8–30.7)
Prostate volume (cc) 22.5 (14.2–51.1)
Bladder volume (cc) 144.1 (34.7–645.1)
Rectal volume (cc)a 42.0 (28.9–55.2)
Rectal mean area (cm2)b 5.86 (4.12–7.46)
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Data analysis and statistics
Correlations between characteristics shown in Table  1 
and the mean prostate shift, the standard devia-
tion (SD) of prostate shift, and the “required margin”, 
were statistically examined. In this study, we defined 
“required margin” as a margin from CTV to PTV, satis-
fying the condition: “interfractional motion of CTV in 
each direction doesn’t exceed PTV with a probability of 
95  %” in each patient. Assuming a normal distribution 
of prostate shift, the “required margin” was calculated 
as follows: “Required margin”  =  (the mean of prostate 
shift) + 1.96 ×  (SD of prostate shift), in every direction 
for each patient. The respective correlations between 
patients’ anatomical characteristics and the required 
margin in six directions (left, right, cranial, caudal, ante-
rior and posterior) or the mean and SD of prostate shift 
in three directions (lateral, craniocaudal and anteropos-
terior) were evaluated by means of linear regression 
analysis. A p value of <0.05 was considered statistically 
significant. JMP software version 9.0.2 (SAS Institute Inc. 
Cary, NC, USA) was used in this study.
Results
A total of 586 MV-CBCT image sets were acquired from 
the 16 patients. Prostate position was clearly identified in 
74–97 % (median 86 %) of the image sets for each patient 
(513 image sets in total, 88 % of all image sets). A sample 
of MV-CBCT image and the corresponding kilovoltage 
CT image at the treatment planning is shown in Fig.  1. 
Rests of the images were not of enough quality to iden-
tify position of prostate. Position of bone structure was 
clearly identified in 92–100  % per patient (altogether 
573 sets, 98 % of the total). Three-dimensional shift (lat-
eral, craniocaudal and anteroposterior) of the prostate is 
shown in Fig. 2a–c, respectively, where the means, ranges 
and “required margins” are shown. For Fig. 2a–c, positive 
values of Y-axis represent the shift in left, cranial, and 
anterior directions, respectively. Note that the positive 
and negative values represent the left/cranial/anterior 
and the right/caudal/posterior motion, respectively. The 
mean and range of “required margin” in each direction is 
shown in Table  2. Correlations between “required mar-
gin” in each direction and patients’ anatomical character-
istics are shown in Table 3. The margin in the posterior 
direction correlated positively with rectal volume and 
rectal mean area (p = 0.015 and p = 0.008, respectively). 
The margin in the anterior and right directions correlated 
negatively with BMI (p  =  0.0047 and 0.0016, respec-
tively), which indicated that a larger BMI correlated with 
a smaller margin. No statistically significant correlations 
were found for the other directions. Next, the mean (sys-
temic error) and the SD (random error) of daily pros-
tate shift were investigated statistically in terms of their 
correlations with patients’ anatomical characteristics 
(Tables 4, 5). The systematic error in the lateral directions 
correlated positively and anteroposterior directions cor-
related negatively with BMI (p = 0.0008 and p = 0.028, 
respectively). The random error in all directions also cor-
related negatively with BMI (lateral, craniocaudal and 
anteroposterior: p = 0.014, 0.04 and 0.0026, respectively).    
Discussion
A significant number of studies have cautioned about 
the problem of interfractional internal motion of the 
prostate, especially in the anteroposterior direction, 
during prostate cancer treatment using EBRT (Bylund 
et  al. 2008; Snir et  al. 2011). Because the volume of the 
rectum easily changes depending on its contents of gas 
Fig. 1 A sample of MV-CBCT image (left) and the corresponding kilovoltage CT image at the treatment planning (right)
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and feces, managements of the anteroposterior motion 
of the prostate during EBRT is of utmost importance in 
terms of two aspects: tumor control and late toxicity. De 
Crevoisier et al. (2005) showed that for intermediate and 
high risk prostate cancer patients, a larger average cross-
sectional rectal area (defined as rectal volume divided by 
its length) was associated with a higher risk of biochemi-
cal failure. This can be explained by the fact that a large 
rectal volume represents a high potential of posterior dis-
placement of the prostate, which might lead to underdos-
ing the tumor if combined with a small posterior margin. 
The association may also be based on the fact that many 
prostate cancer cells are often located at the posterior site 
within the prostate gland (Chen et al. 2000). Interestingly, 
De Crevoisier’s study also showed that the assumption 
of a large rectum for planning CT was associated with 
reduced rectal adverse events. Reddy et al. used B-mode 
trans-abdominal US to show that the prostate tended to 
move posteriorly when the rectal volume on treatment 
planning CT was large, while it tended to move anteriorly 
when the rectal volume was small (Reddy et  al. 2009). 
In support of these studies, our results also showed a 
significant correlation between the required posterior 
margin and the rectal volume or the rectal mean area. 
However, we wish to emphasize that the absolute value of 
the required margin was larger in the anterior direction 
(mean 4.6  mm) than in the posterior direction (mean 
3.1 mm), which may well be attributable to the thorough 
gas suction or encouraging evacuation before planning 
CT used in our study. Although a statistical correlation 
could be found in the posterior direction, the absolute 
influence (required margin) could be kept low by keep-
ing the absolute rectal volume or mean area low. Another 
finding of this study deals with BMI. An increase in setup 
errors in EBRT for overweight patients has been reported 
in the literature (Millender et  al. 2004). In addition, a 
high frequency of biochemical failure for overweight 
patients was also reported (Geinitz et  al. 2011). In con-
trast, patients treated with permanent brachytherapy did 
not show any significant differences in outcome between 
normal and overweight patients (Merrick et  al. 2005), 
which might be explained by the fact that brachytherapy 
Fig. 2 Three dimensional shifts of the prostate in individual patients. 
Lines indicate the range of prostate shift during 35–37 fractions 
for each patient. Dots show the mean of prostate shift from the 
original location determined by CT simulation. Columns represent 
the mean ± 1.96 SD, which indicate the range where the prostate is 
located with a probability of 95 % with an assumption of a normal 
distribution. a–c Lateral, craniocaudal and anteroposterior shift of 
prostate, respectively




 Left 1.7 (0.9–2.8)
 Right 1.9 (1.2–4.4)
Craniocaudal (mm)
 Cranial 3.2 (1.9–4.3)
 Caudal 3.1 (1.0–4.9)
Anterioposterior (mm)
 Anterior 4.6 (1.4–17.0)
 Posterior 3.1 (0.8–6.9)
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was not affected by daily setup errors although caution is 
needed when using EBRT for overweight patients (Wong 
et  al. 2009). Although correlations between daily setup 
errors and the effect of obesity have been thoroughly 
studied, only a few studies have investigated correlation 
between BMI and prostate internal motion. Thompson 
et al. (2011) showed that intrafractional prostate motion 
did not increase in overweight patients, but rather 
decreased in the craniocaudal direction. Since our study 
showed a negative correlation between BMI and extent 
of prostate intefractional internal motion, high BMI may 
thus be a factor that reduces the margin derived from 
prostate internal motion. Male obesity tends to involve 
fat tissue at the trunk compared to female obesity (Cham-
bers et al. 2010), so that we often encounter such patients 
with extra fat at the abdomen. This means that, when 
they are in the supine position, the fat may compress the 
prostate into the caudal and dorsal direction. This may 
be the reason why there were fewer random errors in the 
patients with high BMI in our study, as well as account 
for finding of Thompson’s study that the intrafractional 
craniocaudal motion could be smaller for the overweight 
patients (Thompson et al. 2011). This study also showed a 
negative correlation between BMI and the right margin, 
whereas no correlation was shown between BMI and the 
left margin. This result is assumed to be associated with 
the positive correlation between BMI and systematic 
error to the left direction (Table  4). Although we failed 
to explain the reason of this correlation, we thought the 
clinical importance of this discrepancy would be lim-
ited, because the motion in the lateral direction was the 
smallest in the three directions, with the absolute value of 
lateral systematic error as small as 0.4 mm as the mean, 
with the range from 0.5 mm to 1.5 mm.
This study has several limitations. First, although 
the total number of images evaluated in this study was 
as many as 513, we examined only 16 patients. There 
remains a possibility that these 16 patients were not rep-
resentative of normal population, which may weaken our 
conclusion. Further researches with enough statistical 
power are warranted to establish the definite relationship 
between BMI and random error. Second, we investigated 
only the interfractional motion of the prostate, since an 
examination of intrafractional motion was beyond the 
scope of this study, which is similar to the feature of other 
studies of interfractional prostate motion. The required 
margin as defined in this study can therefore not be uti-
lized as an adequate margin as such in clinical settings. 
In addition, deformation or rotational movement was 
not dealt with in this study. This would indicate that 
the findings obtained from this study would be of only 
Table 3 Correlation between required margin and patients’ anatomical characteristics
† Significantly positive correlation, ††significantly negative correlation
Lateral Craniocaudal Anteroposterior
Left Right Cranial Caudal Anterior Posterior
Age (years old) p = 0.39 p = 0.95 p = 0.40 p = 0.84 p = 0.80 p = 0.46
BMI (kg/m2) p = 0.74 p = 0.0016†† p = 0.36 p = 0.09 p = 0.0047†† p = 0.72
Prostate volume (cc) p = 0.87 p = 0.91 p = 0.93 p = 0.19 p = 0.71 p = 0.46
Bladder volume (cc) p = 0.15 p = 0.95 p = 0.36 p = 0.35 p = 0.29 p = 0.41
Rectal volume (cc) p = 0.18 p = 0.61 p = 0.72 p = 0.70 p = 0.96 p = 0.015†
Rectal mean area (cm2) p = 0.23 p = 0.92 p = 0.57 p = 0.97 p = 0.70 p = 0.008†
Table 4 Correlation between  systematic error (mean 
of prostate shift) and patients’ anatomical characteristics
† Significant positive correlation, i.e. systematic error tends to be left/cranial/
anterior as parameters rise, ††significant negative correlation, i.e. systematic error 
tends to be right/caudal/posterior as parameters rise
Lateral Craniocaudal Anteroposterior
Age (years old) p = 0.75 p = 0.78 p = 0.93
BMI (kg/m2) p = 0.0008† p = 0.42 p = 0.028††
Prostate volume (cc) p = 0.96 p = 0.29 p = 0.68
Bladder volume (cc) p = 0.45 p = 0.21 p = 0.17
Rectal volume (cc) p = 0.28 p = 0.90 p = 0.68
Rectal mean area (cm2) p = 0.55 p = 0.73 p = 0.93
Table 5 Correlation between random error (SD of prostate 
shift) and patients’ anatomical characteristics
†† Significantly negative correlation
Lateral Craniocaudal Anteroposterior
Age (years old) p = 0.71 p = 0.44 p = 0.99
BMI (kg/m2) p = 0.014†† p = 0.04†† p = 0.0026††
Prostate volume (cc) p = 0.94 p = 0.21 p = 0.90
Bladder volume (cc) p = 0.67 p = 0.79 p = 0.44
Rectal volume (cc) p = 0.95 p = 0.55 p = 0.41
Rectal mean area (cm2) p = 0.78 p = 0.72 p = 0.22
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limited value because they become irrelevant for pros-
tate-matching IGRT. However, as prostate-matching pro-
cedure requires sophisticated liniac systems and human 
resources, we believe bone-matching IGRT is still worth 
trying taking into consideration its ease of application 
and that paying attention to BMI is important.
Conclusions
The use of 15 MU MV-CBCT before every fraction of 
IMRT allowed us to evaluate prostate shift on a daily basis 
and required margin. Patients with distended rectum on 
planning CT needed a more posterior margin, as was also 
suggested by previous studies. We found another factor 
influencing interfractional internal prostate motion, that 
is, BMI. Interestingly, a high BMI was associated with a 
smaller motion or a smaller margin, which is quite con-
trary to the belief of the preceding radiotherapy era that 
high BMI is associated with a larger setup error. When 
we treat patients with low BMI or with distended rectum 
on planning CT, setting a relatively larger margin, espe-
cially in anteroposterior direction should be considered, 
as long as bone-matching IGRT is used. In such patients, 
the benefit of prostate-matching IGRT would be greater, 
while brachytherapy might be considered as an alternative 
treatment option. In other words, prostate-matching IGRT 
using fiducial markers or some other, similar technique for 
the treatment for patients with high BMI or whose rectum 
is not distended may yield relatively small gains.
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